. home.aspx


Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis

March 12, 2019

An antibody that blocks the action of a hidden viral protein encoded by our genome shows encouraging signs of slowing down the progression of multiple sclerosis, according to the Swiss biotech GeNeuro which carried out the research. GeNeuro’s monoclonal antibody drug targets the hidden viral protein because it’s linked to the occurrence of multiple sclerosis, a condition that damages the nervous system and causes progressive disability.